Circulars No.6557 and No.6554for the year 2024 regarding Lifting the Recall of Pharmaceutical Product and Field Safety Corrective Actions
21 Aug 2024
Reference: CIR-2024-00000152
To all Health, facilities / all health care practitioners in Dubai's private health sector
Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated
Circular No. 6554 for the year 2024 regarding Lifting the Recall of Pharmaceutical Product Rezzayo 200mg vial
&
Circular No. 6557 for the year 2024 regarding Field Safety Corrective Actions
Thanks in advance for your good co-operation
Drug Control Section
Health Regulation Sector
DHA
downloadDo you find this Content helpful?
Wassel SotakSend Feedback